UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute
by name
Afshari, Natalie A. Brown, Stuart I. Chao, Daniel L. Ferrara, Napoleone Ferreyra, Henry A. Freeman, William R. Goldbaum, Michael H. Granet, David B. Haw, Weldon W. Heichel, Chris W. Kikkawa, Don O. Korn, Bobby S. Lee, Jeffrey E. Lin, Jonathan H. Medeiros, Felipe A. Nguyen, Thao P. Nudleman, Eric Robbins, Shira L. Savino, Peter J. Slight, Rigby Weinreb, Robert N. Welsbie, Derek S. Zhang, Kang
by specialty
Comprehensive Ophthalmology Cornea & Refractive Surgery Glaucoma Neuro-Ophthalmology Ophthalmic Genetics Ophthalmic Pathology Ophthalmic Plastic & Reconstructive Surgery Optometry & Low Vision Pediatric Ophthalmology & Eye Alignment Disorders Retina & Vitreous Thyroid Eye Clinic
by condition
AMD (Age-related Macular Degeneration) Cataracts Corneal Conditions Cosmetic Surgery Diabetic Retinopathy Eye Movement Disorders Glaucoma Hereditary (Genetic) Disorders Low Vision Neuro-Ophthalmic Conditions Ophthalmic Plastic and Reconstructive Surgery Pediatric Conditions Refractive Errors Retinal Diseases Thyroid Eye Disease
Derek S. Welsbie, M.D., Ph.D.

Derek S. Welsbie, M.D., Ph.D.

Assistant Professor of Ophthalmology
Board Certification in Ophthalmology
Fellowship in Glaucoma

Derek S. Welsbie, M.D., Ph.D., is an Assistant Professor of Ophthalmology in the UC San Diego School of Medicine and a board-certified ophthalmologist who has an active medical and surgical practice, specializing in adolescents and adults with all stages of glaucoma.

Dr. Welsbie studies the way in which glaucoma leads to optic nerve injury, neurodegeneration and, ultimately, vision loss. Specifically, he uses high-throughput genetic screening to comprehensively characterize the genes responsible for nerve cell death. His ultimate goal is to develop new medication- and gene therapy-based neuroprotective strategies to interfere with these deleterious genes, prevent nerve cell death and improve outcomes for patients with glaucoma.

Prior to joining UC San Diego Health, Dr. Welsbie was an Assistant Professor at the Johns Hopkins University Wilmer Eye Institute, where he won the Shafer Prize for innovative glaucoma research from the Glaucoma Research Foundation and was named Assistant Professor of the Year (2015). He also served as the Stephen J. Ryan Assistant Chief of Service and continues to have an interest in resident and medical student education.

Dr. Welsbie completed a residency in Ophthalmology and fellowship training in Glaucoma at the Wilmer Eye Institute. He earned his medical degree and doctorate in molecular biology from the David Geffen School of Medicine at UCLA.

Medical School ​University of California, Los Angeles
Residency The Johns Hopkins University School of Medicine/Wilmer Eye Institute
Fellowship The Johns Hopkins University School of Medicine/Wilmer Eye Institute
Special Interest Neuroprotection in glaucoma and other optic neuropathies; Use of functional genomic technologies to identify novel mediators of axon injury signaling in neurons; Development of dual leucine zipper kinase inhibitors; Role of dual leucine zipper kinase in traumatic brain injury

Faculty

Chairman

Whats Your Symptom Disclaimer

The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.

The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.

The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.

Click Here To Accept

Email Us

First Name*
Last Name*
Email*
Phone
MRN
Topic

Required *

Submit